Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • UMC vs GSK✓SelectedUSD · GSKUMC vs GSK performance historyLatest closeAs of-1.39%11/17
Stock and ETF performance explorer

UMC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+133.9%
GSK return
+199.7%
Excess return
-65.8%
Maximum drawdown
-89.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.4%-2.3%+0.9%-0.4%
7D-6.0%-3.0%-3.0%-4.7%
30D-28.7%+0.4%-29.0%-28.9%
3M-27.6%-1.2%-26.4%-27.7%
6M-16.3%+0.9%-17.3%-18.3%
YTD+83.1%+4.0%+79.1%+74.3%
1Y+105.0%+7.3%+97.7%+91.9%
3Y+105.8%+57.1%+48.7%+52.5%
5Y+64.2%+43.0%+21.3%+24.3%
10Y+1,160.4%+103.1%+1,057.4%+639.5%
All+133.9%+199.7%-65.8%-1.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling